measuregroup/AID1162193

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103243148_AID1162193_PMID25176013_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312359485_AID1162193_PMID25176013_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312359466_AID1162193_PMID25176013_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312359469_AID1162193_PMID25176013_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312359484_AID1162193_PMID25176013_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11511
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition of human placental CYP19 using [1beta-3H]androstenedione as substrate at 2 uM by 3H2O-method
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312359466 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312359469 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312359485 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312359484 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103243148
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1162193

Total number of triples: 15.